XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenues        
Product revenue, net $ 24,199 $ 13,483 $ 69,221 $ 42,150
Revenue from Contract with Customer, Product and Service Product Product Product Product
Cost of sales $ 11,513 $ 13,935 $ 31,780 $ 24,249
Gross profit 12,686 (452) 37,441 17,901
Operating expenses        
Research and development 3,726 390 10,742 859
Selling and marketing 9,743 6,597 28,700 18,128
General and administrative 7,615 6,001 23,784 16,948
Acquisition related costs   1,537   2,849
Restructuring costs   4,818   4,875
Impairment expense 45,196 4,286 64,649 4,286
Amortization of intangible assets 1,061 1,585 3,214 4,754
Total operating expenses 67,341 25,214 131,089 52,699
Loss from operations (54,655) (25,666) (93,648) (34,798)
Other income (expense)        
Other income/(expense), net (55) (425) (75) (1,555)
Gain (loss) from contingent consideration 1,257 631 761 (2,680)
Gain (loss) on extinguishment of debt 169   169 (258)
Gain on derivative warrant liability 211   211  
Total other expense 1,582 206 1,066 (4,493)
Loss before income tax (53,073) (25,460) (92,582) (39,291)
Income tax benefit     (110)  
Net loss $ (53,073) $ (25,460) $ (92,472) $ (39,291)
Weighted average number of common shares outstanding - basic (in shares) 29,689,856 18,092,465 27,211,708 14,490,219
Weighted average number of common shares outstanding - diluted (in shares) 29,689,856 18,092,465 27,211,708 14,490,219
Basic net loss per common share (in dollars per share) $ (1.79) $ (1.41) $ (3.40) $ (2.71)
Diluted net loss per common share (in dollars per share) $ (1.79) $ (1.41) $ (3.40) $ (2.71)